%0 Letter
%T Optimising adalimumab administration to improve patient experience and treatment adherence in immune-mediated inflammatory diseases.
%A Misa Garcia A
%A Ferro Rodríguez S
%J Eur J Hosp Pharm
%V 0
%N 0
%D 2024 May 24
%M 38789247
%F 2.537
%R 10.1136/ejhpharm-2024-004229